The FDA approved Milestone Pharmaceuticals' Cardamyst nasal spray for acute episodes of PSVT in adults. First treatment for ...
Cardamyst is now FDA approved as a self-administered intranasal treatment for acute episodes of paroxysmal supraventricular tachycardia.
The self-administered treatment rapidly converts patients into sinus rhythm and may reduce trips to the hospital.
MedPage Today on MSN
Etripamil gets FDA approval for at-home tachycardia conversion
The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), ...
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly ...
Sinus arrhythmia is the variation in heart rate attributable to respiration. Fox and Forges (1985) have found that the “amplitude” of sinus arrhythmia measured near birth is correlated with ...
Dr. Kathleen Maginot answers the question: 'Abnormal Heart Rhythms in Children?' — -- Question: What types of abnormal heart rhythms are more common in children? Answer :There are many ...
A link exists between acute alcohol consumption and cardiac arrhythmias, particularly sinus tachycardia, a study published in European Heart Journal suggests. For the study, German researchers ...
SANTA CLARA, Calif., September 08, 2025--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, ...
A harmless early extra heartbeat and a chaotic, racing, potentially lethal heart rhythm are obviously two different things. Yet, both fit the medical definition of an arrhythmia. "The majority of ...
Unlike any single-lead or 6-lead consumer device, HeartBeam’s patented cable-free technology captures the heart’s electrical signals in three non-coplanar dimensions and synthesizes them into a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results